SPARC and pancreatic ductal adenocarcinoma: Some literatures [36, 37] found that high stromal SPARC expression in the primary tumor might be a biomarker for Nab-PTX treatment of inferior PFS and OS in advanced pancreatic ductal adenocarcinoma and better survival in NSCLC.